We're the make our own pancreas type
JDRF is proud to support the first successful real-world test of a revolutionary closed-loop artificial pancreas system, allowing those with T1D to live as normal a life as possible until there's a cure.
We're the see into the future type
Thanks to your support, JDRF-funded research led to the discovery of Lucentis—the first new therapy with the ability to reverse diabetes-related vision loss in 30 years—creating a brighter future for millions.
We're the beta cell bodyguard type
JDRF is funding clinical trials for encapsulated cell therapies, which will restore insulin independence in those with T1D for an incredible 18 months to two years by implanting newly created insulin-producing beta cells into a protective capsule, so they can do their job, and those with T1D can enjoy a little freedom.
(including Smart Insulin)
We're the making insulin smarter type
JDRF is funding the early development of smart insulin. A single daily dose of insulin circulates in the bloodstream turning on when it's needed and off when it's not giving those with T1D perfect blood-glucose control throughout the day.
We're the help the body heal type
JDRF is funding research on restoration, a potential biological cure for T1D that taps into the body’s amazing power to heal itself, restoring beta cells’ ability to produce insulin while thwarting the autoimmune attack that triggers T1D.
We're the stop it before it starts type
Thanks to you, JDRF is able to support work on a vaccine to slow or stop the progression of T1D before insulin dependence occurs. For those at risk of T1D, prevention is powerful medicine.